Skip to main content
. 2021 Nov 16;7:357. doi: 10.1038/s41420-021-00750-3

Fig. 2. UBE2S enhances resistance of HCC cells to 5-FU and oxaliplatin.

Fig. 2

A UBE2S protein levels in five HCC cell lines were determined by western blot. BE Cytotoxicity curves show the cytotoxic effects of 5-FU (B) and oxaliplatin (D) on five different HCC cell lines. Bar graphs (C, E) show the IC50 values of n = 3 independent experiments. F UBE2S knockdown and overexpression rescue were validated by western blot in Huh7 and PLC/PRF/5 cells, respectively. GJ Cytotoxic effects of 5-FU on UBE2S-knockdown and UBE2S-rescue (knockdown + overexpression) Huh7 (G, H) and PLC/PRF/5 (I, J) cells and control (NTC + Vec) cells were determined by CCK-8 assays, respectively. KN Cytotoxic effects of oxaliplatin on UBE2S-knockdown and UBE2S-rescue Huh7 (K, L) and PLC/PRF/5 (M, N) cells and control cells were determined, respectively. O UBE2S overexpression efficiency was validated by western blot in Hep3B and HepG2 cells, respectively. PS Cytotoxic effects of 5-FU on UBE2S-overexpression Hep3B (P, Q) and HepG2 (R and S) cells and vector control (Vec) cells were determined by CCK-8 assays, respectively. TW Cytotoxic effects of oxaliplatin on UBE2S-overexpression Hep3B (T, U) and HepG2 (V, W) cells and Vec cells were determined, respectively.